Method of treating lung diseases with uridine 5'-diphosphate and

Details Method of treating lung diseases with uridine 5'-diphosphate and Method of treating lung diseases with uridine 5'-diphosphate and

1999-07-13

2000-02-08

Bawa, Raj

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

424 46, 514851, 514826, A61K 912

Patent

active

060225270

ABSTRACT:
Compounds of Formula I: ##STR1## wherein: X.sub.1, and X.sub.2 are each independently either O.sup.- or S.sup.- ;

REFERENCES:
patent: 3313813 (1967-04-01), Cragoe et al.
patent: 3846402 (1974-11-01), Eckstein et al.
patent: 4501729 (1985-02-01), Boucher et al.
patent: 5292498 (1994-03-01), Boucher, Jr.
patent: 5420116 (1995-05-01), Puchelle et al.
patent: 5628984 (1997-05-01), Boucher, Jr.
patent: 5635160 (1997-06-01), Stutts, III et al.
patent: 5656256 (1997-08-01), Boucher et al.
Eric A. Barnard; Hexokinases from Yeast, Methods in Enzymology 42:6-20 (1975).
Brown et al.; Evidence that UTP and ATP Regulate Phospholipase C through a Common Extracellular 5'-Nucleotide Receptor in Human Airway Epithelial Cells, Molecular Pharmacology 40:648-655.
Chang et al.; Molecular Cloning and Functional Analysis of a Novel P.sub.2 Nuecloetide Receptor, The Journal of Biological Chemistry, 270, No. 44:26152-26158.
S.H. Donaldson et al; In Vivo Regulation of ATP Levels in Human Nasal Epithelia, Pediatric Pulmonology Supp.; 13, 290 (Abstract No. 286) (1996).
Erb et al; Site-directed Mutagenesis of P.sub.2u Purinoceptors, The Journal of Biological Chemistry 270:4185-4188 (1995).
Goody et al; Thiophasphate Analogs of Nucleoside Di- and Triphosphates, Journal of the American Chemical Society 93:6252-6258 (1971).
Knowles et al., Activation by Extracellular Nucleotides of Chloride Secretion in the Airway Epithelia of Patients with Cystic Fibrosis, New England Journal of Medicine, 325:533-538 (Aug. 22, 1991).
Knowles et al; Extracellular ATP and UTP Induce Chloride Secretion in Nasal Epithelia of Cystic Fibrosis Patients and Normal Subject in vivo, Chest 101:60S-63S (Mar. 1992 Supplement).
Knowles et al; Abnormal Ion Permeation Through Cystic Fibrosis Respiratory Epithelium Science 221:1067-1069 (1983).
Knowles et al; Relative Ion Permeability of Normal and Cystic Fibrosis Nasal Epithelium, J. Clinical Invest. 71:1410-1417 (May 1983).
Larsen et al; Cation Transport by Sweat Ducts in Primary Culture, Ionic Mechanism of Cholinergically Evoked Current Oscillations Journal of Physiology 424:109-131 (1990).
Lazarowski et al; Identification of a Uridine Nucleotide-selective G-protein-linked Receptor that Activates Phospholipase C, The Journal of Biological Chemistry 269(11830-11836) (1994).
Lazarowski et al; Pharmacological selectivity of the cloned human P.sub.2u -puriniceptor potent activation by diadenosine tetraphosphate Br. J. Pharmacol. 116:1619-1627 (1995).
Lazarowski et al; Enzymatic synthesis of UTP.sub..gamma. S, a potent hydrolysis resistant agonist of P.sub.2u -purinoreceptors, British Journal of Pharmacology 117:203-209 (1996).
Lazarowski et al; Mucosal-Restricted P.sub.2u -Receptor Independent Action of UDP on Human Nasal Epithelial Cells; Pediatric Pulmonology Supp 13, 290 (Abstract No. 292) (1996).
Nakahata et al.; Regulation of inositol triphosphate accumulation by muscarinic cholinergic and H.sub.1 -histamine receptors on human astrocytoma cells, Biochem J. 241:337-344 (1987).
Mason et al; Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium Br. J. Pharmacol. 103:1649-1656 (1991).
Nicholas et al; Uridine Nucleotide Selectivity of Three Phospholipase C-Activating P.sub.2 Receptors: Identification of a UDP-Selective, a UTP-Selective, and an ATP- and UTP-Specific Receptor Molecular Pharmacology, 50:224-229 (1996).
Olivier et al.; Acute Safety and Effects on Mucociliary Clearance of Aerosolized Uridine 5'-Triphosphate .+-.Amiloride in Normal Human Adults Am j Respir Crit Care Med 154:217-223 (1996).
Paradiso et al; Membrane-restricted regulation of Ca.sup.2+ release and influx in polarized epithelia Nature 377:643-646 (Oct. 19, 1995).
Parr et al; Cloning and expression of a human P.sub.2u nucleotide receptor, a target for cystic fibrosis pharmacotherapy Proc. Natl. Acad. Sci. USA 91:3275-3279 (Apr. 1994).
Stutts et al; Multiple modes of regulation of airway epithelial chloride secretion by extracellular ATP American Physiological Society 267:C1442-C1451 (1994).
Wu et al; Growth and Differentiation of Human Nasal Epithelial Cells in Culture, Am Rev Respir Dis 132:311-320 (1985).

Affiliated with

Also associated with

Rating

Method of treating lung diseases with uridine 5'-diphosphate and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating lung diseases with uridine 5'-diphosphate and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating lung diseases with uridine 5'-diphosphate and will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1678536